CARsgen Therapeutics raises $30 mln
CARsgen Therapeutics said Monday it completed a $30 million Series B round led by KTB Ventures and Jolly Innovation Ventures. Kaitai Capital and JIC GenesisFountain Healthcare Ventures also participated. CARsgen Therapeutics, of Shanghai, is developing CAR-T-based autologous immunotherapy to treat solid tumors.
26 January 2016•3 mins read
